Search
Skip to Search Results- 18Alzheimer's disease
- 13Meta-analysis
- 4Systematic reviews
- 3Amyloid precursor protein
- 2Amyloid beta
- 2Autophagy
- 1Barrington, Catherine
- 1Cochrane, Karen
- 1Davis, Christopher MJ
- 1Drouin, Shannon
- 1Ellis, Rebecca K.
- 1Fedor, Brittany A
-
Spring 2016
There is ample evidence that autophagy is affected in Alzheimer’s disease (AD) but the causes, the nature of the dysfunction and the mechanisms of autophagy impairment are unclear. Autophagy depends on vesicular trafficking and membrane fusion, events that rely on several protein complexes and...
-
Fall 2019
Alzheimer’s disease (AD) is characterized by the accumulation of amyloid beta (Aβ) peptide. It has been proposed that AD pathology is transmissible by a “prion-like” mechanism through extracellular vesicles (EVs) that contain Aβ. In this context, EVs describe both microvesicles and exosomes,...
-
Spring 2022
Carotid atherosclerosis is responsible for 15-25% of the nearly 8 million first-ever ischemic strokes that occur each year worldwide. This proportion has remained constant over the past three decades, thus suggesting that some patients with carotid atherosclerosis currently receive suboptimal...
-
Fall 2021
The field of animal personality, the study of adaptive among-individual behavioural differences in animal populations, has both exploded in popularity in the last few decades and come under heavy scrutiny by behavioural ecologists. The sudden interest in the field stems from the widespread...
-
Cellular level/distribution of γ-secretase subunit nicastrin and its modulator p23 in the brain
DownloadSpring 2010
The processing of amyloid precursor protein (APP) by β- and γ-secretases produces amyloid β (Aβ) peptide, the principal component of the neuritic plaques found in Alzheimer’s disease (AD) pathology. The enzyme γ-secretase is a multimeric protein consisting of presenilins-1/2 (PS1/PS2), nicastrin,...
-
Spring 2013
Alzheimer’s disease (AD) is a complex neurodegenerative disorder believed to be triggered by the accumulation of β-amyloid (Aβ)-related peptides derived from the proteolytic processing of amyloid precursor protein (APP). Research over the last two decades has shown that alterations in the levels...
-
Data-Driven Approaches to Modeling Heterogeneity and Variability Across Asymptomatic Brain and Cognitive Aging, Mild Cognitive Impairment, and Alzheimer’s disease
DownloadSpring 2024
Objective We apply data-driven approaches to identify predictors of heterogeneous trajectories across normal aging, Mild Cognitive Impairment (MCI), and Alzheimer’s disease (AD). In Study 1, we investigated predictors of left and right hippocampal (HC) volume trajectory classes. In Study 2, we...
-
Diminishing Returns in Cardiovascular Disease Research: Systematic Review and Meta-analysis
DownloadFall 2019
If “usual care” improves with time, it becomes increasingly difficult for new therapies to demonstrate additional benefit. Our objective then was to determine, by systematic review of randomized trials, whether the absolute cardiovascular risk reduction attributed to community-implemented...